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Introduction: Parenteral nutrition (PN) formulations are commonly individualized, since 
their standardization appears inadequate for the pediatric population. This study aimed 
to evaluate the nutritional state and the reasons for PN individualization in pediatric 
patients using PN, hospitalized in a tertiary hospital in Campinas, São Paulo. 
Methods: This longitudinal study comprised patients using PN followed by up to 67 
days. 
Nutritional status was classified according to the criteria established by the World Health 
Organization (WHO) (2006) and WHO (2007). The levels of the following elements in blood 
were analyzed: sodium, potassium, ionized calcium, chloride, magnesium, inorganic 
phosphorus, and triglycerides (TGL). Among the criteria for individualization, the 
following were considered undeniable: significant reduction in blood levels of potassium 
(<3mEq/L), sodium (<125mEq/L), magnesium (<1mEq/L), phosphorus (<1.5mEq/L), ionic 
calcium (<1mmol), and chloride (<90mEq/L), or any value above the references. 
Results: Twelve pediatric patients aged 1 month to 15 years were studied (49 
individualizations). most patients were classified as malnourished. It was observed that 
74/254 (29.2%) of examinations demanded individualized PN for indubitable reasons. 
Conclusion: The nutritional state of patients was considered critical in most cases. Thus, 
the individualization performed in the beginning of PN for energy protein adequacy was 
indispensable. In addition, the individualized PN was indispensable in at least 29.2% of 
PN for correction of alterations found in biochemical parameters. 
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
☆Study conducted at Universidade Estadual de Campinas, Campinas, SP, Brazil.
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Introduction
In 1968, Dudrick, Vars, and Rhoads1 became famous 
for starting parenteral nutrition (PN) formulations.2 In 
1972, Solassol and Joyeux reported the successful use 
of the parenteral formula that would become known 
as 3-in-1, containing amino acids, a glucose and lipid 
emulsion, as well as electrolytes, vitamins, and trace 
elements.3 PN is an effective nutritional strategy for 
survival, but it is associated with clinical complications 
such as infections, metabolic and minerals disorders, 
hypertriglyceridemia, and liver alterations.4 According to 
the American Society for Parenteral & Enteral Nutrition 
(ASPEN),5 PN is a complex therapy associated with adverse 
effects, and even death, when safety guidelines are not 
followed. Thus, for an appropriate and safe prescription, 
it is necessary to meet the needs of protein, energy, 
macronutrients, micronutrients, fluid homeostasis, and 
acid-base balance. 
The PN formula can be standardized or individualized for 
adults. Regarding the pediatric population, the formulations 
are commonly individualized due to peculiarities related 
to growth and development and, consequently, different 
nutritional demands. However, there have been an 
increasing number of studies on standardized 3-in-1 PN 
(industrialized) for children. According to Colomb et al6 
and Rigo et al,7 the advantages of using the standardized 
solution are: reduction in the risk of infection, decrease in 
prescription errors and complications caused by inadequate 
use of incompatible compounds, and easy handling reported 
by health professionals.
Considering that, in Brazil, the use of standardized PN 
is not a common practice in Pediatrics, and with regard to 
the abovementioned facts, the aim of the present study 
was to evaluate the nutritional status and the reasons for 
PN individualization in pediatric patients receiving PN in a 
tertiary hospital in Campinas-SP. 
Method
This was a longitudinal study performed in 12 patients receiving 
PN, admitted to the pediatric ward and the pediatric intensive 
care unit (PICU) of a tertiary hospital in Campinas-SP. Patients 
were followed for up to 67 days of PN use.
The study inclusion criteria were: use of individualized 
PN, and signature of the informed consent by the parents/
guardians. When the PN was discontinued, but the patient 
subsequently started receiving it again, this patient 
was included in the study only with regard to the first 
instance.
The weight and height of patients were measured 
according to the techniques proposed by the World Health 
Organization (WHO)8 and Lohman, Roche, and martorell.9 
The instruments used were: stadiometer (to the nearest 
0.1cm), electronic Filizola scale (Filizola® – São Paulo, 
Brazil) (capacity of 2.5kg to 150kg), and Toledo digital scale 
(Toledo® – São Paulo, Brazil ) (capacity of 0.1kg to 15kg).
deve-se individualizar a nutrição parenteral pediátrica?
Resumo 
Introdução: As formulações da nutrição parenteral (NP) são comumente individualiza-
das, visto que a padronização destas parece inadequada para a população pediátrica. 
O objetivo do estudo foi avaliar o estado nutricional e os motivos para individualização 
da NP dos pacientes pediátricos em uso de NP internados em um hospital terciário de 
Campinas-SP. 
Métodos: Estudo longitudinal conduzido com pacientes acompanhados por até 67 dias de 
uso de NP. Para a classificação do estado nutricional, foram utilizados os critérios propos-
tos pela World Health Organization (WHO) (2006) e WHO (2007). As dosagens sanguíneas 
analisadas foram: sódio, potássio, cálcio iônico, cloreto, magnésio, fósforo inorgânico e 
triglicerídeo (TGL). Foram considerados motivos indubitáveis para individualização da NP 
quando esses elementos apresentavam redução expressiva dos níveis sanguíneos (potás-
sio <3 mEq/L; sódio <125 mEq/L; magnésio <1 mEq/L; fósforo <1,5 mEq/L; cálcio iônico 
<1 mmol/L; cloreto <90 mEq/L) ou qualquer valor superior aos de referência. 
Resultados: Foram estudados 12 pacientes (49 individualizações) com idade de 1 mês 
a 15 anos. A maioria dos pacientes foi classificada como desnutrida. Observou-se que 
74/254 (29,2%) dos exames demandaram NP individualizada por motivos indubitáveis.
Conclusão: O estado nutricional dos pacientes foi considerado crítico, na maioria dos 
casos. Desta forma, a individualização realizada no início da NP para a adequação ener-
gética proteica foi essencial. Além disto, a NP individualizada foi indispensável em, no 
mínimo, 29,2% das NP, para correção das alterações encontradas nos exames bioquími-
cos. 
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Nutritional status was classified according to the criteria 
proposed by the WHO10,11 as follows: 
— For the variable weight/age: z-score <-3 is equivalent 
to very low weight for age; z-score between -3 and -2 is 
equivalent to low weight for age; z-score is ≥-2 and ≤+2 
is equivalent to adequate weight for age; z-score >+2 is 
equivalent to high weight for age. This variable was used 
to classify the nutritional status of patients younger than 
10 years of age.
— For the variable BmI/age: z-score < -3 is equivalent 
to severe underweight; z-score between -3 and -2 is 
equivalent to underweight; z-score ≥-2 and ≤+1 is within 
the normal range; z-score between +1 and +2 is equivalent 
to overweight; z-score between +2 and +3 is equivalent 
to obesity; z-score is > +3 is equivalent to severe obesity. 
This variable was used to classify the nutritional status 
of patients older than 10 years of age and was not been 
applied to patients younger than 10 years due to the 
difficulty of data collection for height.
To monitor patients receiving PN, it is the routine of the 
nutrition support team service to perform laboratory tests, 
as recommended by ASPEN.2-12 Study data included those 
of up to 24 prior to individualization or re-individualization 
of the PN bag. Blood measurements of sodium, potassium, 
ionized calcium, chloride (method: ion selective 
electrode), magnesium (method: colorimetric xilidil blue), 
inorganic phosphorus (method: UV phosphomolybdate), 
and triglycerides (method: colorimetric enzyme) were 
performed at the Clinical Pathology Laboratory of Hospital 
de Clínicas, a tertiary hospital in Campinas. Table 1 
shows the reference values  used by the Clinical Pathology 
Laboratory.
The criteria used for individualization of PN were: 
protein-energy adequacy, performed when the patient 
starts the PN; Protein-energy re-adequacy, performed 
after the start of the PN; hyponatremia; hypernatremia; 
hypokalemia; hyperkalemia; hypocalcemia; hypercalcemia; 
hypomagnesemia; hypermagnesemia; hypophosphatemia; 
hyperphosphatemia; hypochloremia; hyperchloremia; and 
hypertriglyceridemia. Among the individualization criteria, 
the following were considered indisputable: significant 
reduction in blood levels (potassium <3mEq/L, sodium 
<125mEq/L, magnesium <1mEq/L, phosphorus <1.5mEq/L, 
ionic calcium <1 mmol/L, chloride <90 mEq/L), or any 
value higher than the reference value. For higher values, 
the need for individualization was  considered indisputable, 
as the infusion discontinuation is the first necessary 
measure. In the case of triglycerides, values >250mg/dL 
were considered.
The PN was prescribed by a physician specialized in 
nutrition and a specialist in parenteral and enteral nutrition 
working in the nutrition support team. The prescribed 
amounts were generally in agreement with ASPEN13 and 
the European Society for Pediatric Gastroenterology, 
Hepatology, and Nutrition (ESPGHAN).14 However, in some 
cases there was initial modification, or during evolution, 
according to the nutritional and laboratory assessment. The 
pharmacochemical standards were respected in all cases 
and attested by the pharmacist of the nutrition support 
team and by the professional in charge of preparing the 
formulation, according to Board Resolution No. 63, of 
07/06/2000.15
The SPSS® release 17 was used to assess the frequencies 
and perform the descriptive analysis of the data. 
The project was approved by the Ethics Committee of 
the School of medical Sciences, Universidade Estadual de 
Campinas (No 538/2011). 
Results
A total of 12 patients (nine males and three females) were 
studied, with a total of 49 individualizations. The assessed 
patients’ age ranged from 4 months to 15 years and 4 
months, with exclusive PN in 39/49 (79.6%).
Table 1 Reference values  used by the Laboratory of Clinical Pathology, Hospital de Clinícas, Universidade Estadual de 
Campinas, Campinas, Brazil.
Element Reference
Sodium ≤1 year=≥129≤143mEq/L 
 >1 year=≥132≤145mEq/L
Potassium >4 months 1 year=≥3.6≤5.8mEq/L 
 >1 year=≥3.5≤5.1mEq/L
Ionic calcium  ≥1.15 ≤1.29 mmol/L
magnesium ≤6 years=≥1.4≤1.88mEq/L
 6-12 years=≥1.4≤1.72mEq/L 
 ≥12 years=≥1.4≤1.8mEq/L
Chloride ≥96≤107mEq/L
Phosphorus 1 month 1 year=M=≥3.5≤6.6mEq/L and F=≥3.7≤6.5mEq/L
 4-6 years=M ≥3.3≤5.6mEq/L and F ≥3.2≤5.5mEq/L
 7-9 years=M ≥3≤5.4mEq/L and F ≥3.1≤5.5mEq/L
 10-12 years=M ≥3.2≤5.7mEq/L and F ≥3.3≤5.3 mEq/L
 13-15 years=M ≥2.9≤5.1mEq/L and F ≥2.8≤4.8mEq/L
Triglycerides <200mg/dL
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Table 2 Description of the sample according to age, nutritional status, time of evaluation, PN route of administration, number 
of individualizations performed in each patient, place of hospitalization, and outcome.
Patient Age Z-score Days of  Number of Place of Outcome 
   assessment  individualizations hospitalization  
1 15 years and 4 months -3.12a 11 4 Ward Discharge 
2 4 months -3.78b 9 2 ICU Death 
3 13 years and 3 months - 13 2 Ward Discharge
4 7 months -3.87b 4 1 ICU Discharge 
5 7 months -5,67b 2 1 ICU Death 
6 1 year and 2 months -3.6b 8 4 Ward Discharge 
7 1 year and 4 months -8.44b 47 4 ICU Continuing   
      Hospitalizationc
8 11 years and 1 month -3,13a 12 5 ICU Discharge 
9 5 months -6.39b 53 4 ICU Death 
10 4 months -1.85b 60 3 Ward Continuing  
      Hospitalizationc
11 5 years and 9 months -0.14b 55 10 Ward Continuing  
      Hospitalizationc
12 3 years and 9 months -2.01b 67 9 ICU Continuing  
      Hospitalizationc
aBody mass index/age. bweight/age. cContinuing Hospitalization. The patient still continues to receive PN and/or remains in the 
hospital.
Table 3 Adequacy of laboratory tests in the 24 hours prior to the first individualization and the other re-individualizations.
 Tests 24 hours before the first individualization Tests 24 hours before the other   
  individualizations
 Low levels n (%) High levels n (%) Low levels n (%) High levels n (%)
Sodium 2 (16.7) 1 (8.3) 10 (29.4) 5 (14.7)
Potassium 5 (41.7) - 12 (35.3) 2 (5.9)
Ionic calcium 4 (36.4) 2 (18.2) 11 (34.4) 1 (3.1)
Phosphorus 2 (18.2) 3 (27.3) 5 (17.3) 9 (31.0)
Magnesium 5 (45.5) 1 (9.1) 10 (34.5) 6 (20.7)
chloride 1 (9.1) 4 (36.4) 1 (3.1) 10 (31.3)
Triglycerides - 2 (20.0) - 20 (87.0)
Table 4 Percentage of unquestionable reasons for the need of individualization, according to blood levels.
Tests Total  High High levels Levels with Levels with critical 
 tests  levels in relation critical reduction in 
 performed  to total tests reduction relation to total tests
 n n % n %
Sodium 44 6 13.6 2 4.5
Potassium 44 2 4.5 6 13.6
Magnesium 38 7 18.4 1 2.6
Ionic calcium  41 3 7.3 1 2.4
Phosphorus 38 11 28.9 1 2.6
chloride 49 14 28.6 2 4.1
TGL 33 9 27.3 9 27.3
Total 254 52 20.5 22 8.7
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Table 2 shows the age, nutritional status, time of 
assessment, the number of individualizations performed 
for each patient, place of admission, and patient outcome. 
The nutritional status of patients, according to the weight/
age, was rated as very low weight (n=6), low weight (n=1), 
or adequate weight for age (n=2). Two adolescents were 
classified as having severe underweight according to BmI/
age (Table 2).
Table 3 shows that, with the exception of ionic calcium 
and magnesium, laboratory tests were within the reference 
values  in most cases assessed for the 1st individualization. 
Regarding the re-individualizations, it was observed that 
magnesium and triglycerides levels were, most of times, 
out of the reference range. 
Table 4 shows that 74/254 (29.2%) of the assessments 
required PN individualization due to unquestionable 
reasons, according to blood levels. 
At the start of PN use, protein-energy adequacy was 
observed in accordance with clinical and nutritional status as 
the only indication or associated to individualization (n=12, 
100%). Later, when there was need for re-individualizations, 
protein-energy readjustment was the main reason in 13/37 
(35.2%) cases.
discussion
The nutritional status of the hospitalized patient suffers 
the actions of metabolic stress. Critical pediatric patients, 
especially infants and children, are very vulnerable to the 
consequences generated by this situation. During the stress 
process, there is a loss of fatty tissue as well as muscle, 
which can aggravate malnutrition and significantly impair 
response to the disease.
The majority of the assessed patients were admitted to 
the PICU with exclusive PN, of whom 63.6% were classified 
as having severe malnutrition. Knowing that body weight 
may be “masked” due to the inflammatory process with 
presence of edema, it is possible that the nutritional status 
of these patients was underestimated, which may raise this 
malnutrition percentage. Severe malnutrition was found 
mostly in children aged <1 year and 2 months. This can be 
explained by the fact that infants are more susceptible to 
losses of nutritional status in relation to older children. 
Therefore, the offered nutrition support is of utmost 
importance for patient survival and recovery.16
Nutritional support through PN is one of the ways to 
improve nutritional status. In pediatrics, PN is commonly 
individualized; its main advantage is the specific 
prescription according to the nutritional needs and the 
clinical condition of patients.17 In the present study, 
at first, the PN of all patients was individualized due 
to protein-energy adequacy, as the only or associated 
indication. Later, when re-individualizations were 
required, protein-energy readjustment was the reason 
for re-individualizations in 35.2% of cases. However, 
standardized PN has been identified as a strategic option 
in some studies.6,7
These studies reported the possible benefits of 
standardized PN, such as reducing the risk of infection; 
however, these studies are not comparative. Other 
advantages mentioned in the studies include the reduction 
in prescription errors; decrease in complications caused 
by inadequate use of incompatible compounds; and easy 
handling, reported by health professionals.6,7
According to the studies by Agostoni18 and Colomb et 
al,6 most hospitals do not have trained professionals to 
prescribe PN. Furthermore, few units have adequate 
conditions to prepare the prescribed PN formula. In Brazil, 
these conditions are regulated by current legislation (Board 
Resolution No. 63 of 07/06/2000).15 
Riskin, Shiff, and Shamir,17 verified, through telephone 
consultations, that of the 25 NICUs in Israel, 18 used 
standardized PN. moreover, among the seven NICUs that 
used individualized PN, six stored standardized PN for 
weekends and evenings. In Israel, most NICUs are small- and 
mid-sized and there is no readily available nutrition support 
team. Thus, the authors suggest the use of standardized 
PN for most newborns and individualized PN for those who 
need it. However, according to ASPEN,19 in some cases, such 
as neonates, pediatric, and critically-ill patients, the use of 
standardized PN can be difficult.
In Brazil, the individualized PN bags are prescribed by 
the physician and formulated under the supervision of a 
pharmacist, in accordance with current legislation (Board 
Resolution No. 63 of 07/06/2000),15 which defines the 
necessary care and controls in the practice of nutritional 
therapy, including the need of a nutrition support team, 
which must necessarily be comprised of at least one 
professional from each category (doctor, nutritionist, nurse, 
pharmacist, and may include other professional according 
to the hospital) with specific training.15 
moreover, in many places, including Europe and Brazil, 
computer programs are used to calculate the prescription of 
individualized PN, helping to prevent the errors mentioned 
by the authors that argue in favor of standardized PN use, 
such as technical drug errors. Furthermore, computer 
programs coordinate the easy handling and convenience of 
use and communication between the pharmacy and the PN 
prescription staff.6
In the study by Colomb et al,6 two standard PN formulas 
(one for term newborns to children aged up to 2 years 
and another for children aged 2-18 years) were used. 
Approximately 30% of patients were not included in the 
study due to the need for individualization. However, the 
authors state that in clinical practice, these could be 
included, because the limitations outweigh the risks when 
the PN is used in the short term. According to ASPEN,4 
PN formulations are often individualized and standardized 
PN may be an alternative. According to the ESPGHAN,14 a 
standardized PN formula may be used for short periods 
(up to two weeks); however, the individualized PN is 
preferable.14-18
In the present study, one to ten PN individualizations 
were conducted for each patient during the evaluation 
period (2-67 days). Although it is not possible to affirm, 
it can be speculated that PN use for a longer period 
of time results in a higher cumulative possibility of 
mineral and TGL disturbances. In fact, the possibility 
of mineral disturbances is a limiting factor for the 
prescription of PN. Among the sample patients, 10/12 
(83.3%) required at least one re-individualization during 
Should pediatric parenteral nutrition be individualized? 331
PN use. According to all tests performed, 20.5% had 
values above and 8.7% had values below the reference 
values, which is considered an unquestionable reason 
for PN individualization. 
Therefore, 29.2% were considered indisputable. In the 
study by Krohn et al,19 PICU patients were evaluated with 
standardized or individualized PN. The authors noted that 
54% of the standardized PN required modifications. That 
is, it was necessary to carry out PN individualization during 
its use.
As for laboratory tests performed 24 hours before 
the first individualization, in this study, most were in 
agreement with the reference values,  except for ionic 
calcium and magnesium. Subsequently, an increase was 
observed in the inadequacies (especially TGL, phosphorus, 
and magnesium). mineral disorders are common, especially 
because the sample included severely ill patients. Thus, PN 
re-individualizations were necessary to control the clinical 
picture. 
Several studies with patients admitted in PICUs 
reported changes in levels of magnesium,21 potassium,22 
phosphate,23 and ionic calcium,24 and the association 
of these alterations with clinical complications. As for 
hypertriglyceridemia, it may be associated with the 
use of PN and metabolic stress, which may be due to 
the disease or a pre-condition. Regarding the presence 
of hypomagnesemia, the frequent of use of thiazide 
diuretics, and especially loop diuretics in critically ill 
patients, explains its high incidence in this study. In 
fact, the literature reports a prevalence of 20-70% of 
hypomagnesemia in critically-ill patients.21 
Therefore, blood levels of minerals should be monitored 
frequently and the volume and the adequate amount 
should be administered in the PN, always assessing 
the infused medications, the drug compatibility of the 
solution, and variations resulting from the disease. Thus, 
the PN for pediatric patients should be individualized and 
the legislation should be followed, so that the safety and 
effectiveness of the therapy are guaranteed.
It can be concluded that, in the present study, PN 
individualizations were essential for an adequate energy-
protein intake due to impaired nutritional status and 
correction of abnormalities found in biochemical tests. 
Studies with larger samples may or may not confirm these 
findings in their entirety. Nevertheless, for pediatric patients, 
there is a clear need for PN individualization prescribed 
by professionals (the nutrition support team), aided and 
supervised by the hospital pharmacies. This seems to be the 
safest and most effective way to prescribe PN. 
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